Solubility enhancement and physicochemical characterization of carvedilol solid dispersion with Gelucire 50/13

Archives of Pharmacal Research

Volumn 34, Issue 1, 2011, Pages 51-57

  Potluri, Raja Hemanth Kumar ^a   Bandari, Suresh ^a   Jukanti, Raju ^a   Veerareddy, Prabhakar Reddy ^a  

^a ST PETER'S INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Carvedilol; Dissolution; Gelucire; Solid dispersion

Indexed keywords

CARVEDILOL; GELUCIRE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG RELEASE; DRUG SOLUBILITY; DRUG TRANSFORMATION; EVAPORATION; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; X RAY DIFFRACTION;

ANTIHYPERTENSIVE AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CARBAZOLES; CRYSTALLIZATION; DRUG CARRIERS; FATS; MICROSCOPY, ELECTRON, SCANNING; OILS; PROPANOLAMINES; SOLUBILITY; X-RAY DIFFRACTION;

EID: 79955055728     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0106-3     Document Type: Article

References (28)

1. M. Barzegar-Jalali N. Maleki A. Garjani A. A. Khandar M. Haji-Hosseinloo R. Jabbari S. Dastmalchi 2002 Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique Drug Dev. Ind. Pharm. 28 681 686 12149960 10.1081/DDC-120003859 1:CAS:528: DC%2BD38Xls1Onsbc%3D (Pubitemid 34809567)
2. G. V. Betageri K. R. Makarla 1996 Characterization of glyburide-polyethylene glycol solid dispersion Drug Dev. Ind. Pharm. 22 731 734 10.3109/03639049609063230 1:CAS:528:DyaK28XktVars7c%3D (Pubitemid 26245761)
3. B. Chauhan S. Shimpi A. Paradkar 2005 Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique AAPS PharmSciTech 6 E405 E412 16353998 10.1208/pt060350 (Pubitemid 41631777)
4. W. L. Chiou S. Riegelman 1971 Pharmaceutical applications of solid dispersion system J. Pharm. Sci. 60 1281 1302 4935981 10.1002/jps.2600600902 1:STN:280:DyaE3M3otFersQ%3D%3D
5. F. Damian N. Blaton L. Naesens J. Balzarini R. Kinget P. Augustijns G. Van den Mooter 2000 Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14 Eur. J. Pharm. Sci. 10 311 322 10838021 10.1016/S0928-0987(00)00084-1 1:CAS:528:DC%2BD3cXjs1Cgs78%3D (Pubitemid 30317467)
6. C. J. Dunn A. P. Lea A. J. Wagstaff 1997 Carvedilol-a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders Drugs. 54 161 185 9211087 10.2165/00003495-199754010-00015 1:CAS:528: DyaK2sXks1eisbc%3D (Pubitemid 27300048)
7. A. Fini J. R. Moyano J. M. Ginés J. I. Perez-Martinez A. M. Rabasco 2005 Diclofenac salts II. Solid dispersions in PEG 6000 and Gelucire 50/13 Eur. J. Pharm. Biopharm. 60 99 111 15848062 10.1016/j.ejpb.2004.11.005 1:CAS:528:DC%2BD2MXjsVehtro%3D (Pubitemid 40545866)
8. M. Franco G. Trapani A. Latrofa C. Tullio M. R. Provenzano M. Serra M. Muggironi G. Biggio G. Liso 2001 Dissolution properties and anticonvulsant activity of phenytoin polyethylene glycol 6000 and -polyvinylpyrrolidone K-30 solid dispersions Int. J. Pharm. 225 63 73 11489555 10.1016/S0378-5173(01)00751- 7 1:CAS:528:DC%2BD3MXlslant7g%3D (Pubitemid 32728200)
9. M. K. Ghorab M. C. Adeyeye 2001 Enhancement of ibuprofen, dissolution via wet granulation with beta-cyclodextrin Pharm. Dev. Technol. 6 305 314 11485172 10.1081/PDT-100002611 1:CAS:528:DC%2BD3MXls1Wms7o%3D (Pubitemid 32678236)
10. B. C. Hancock G. Zografi 1997 Characteristics and significance of the amorphous state in pharmaceutical systems J. Pharm. Sci. 86 1 12 9002452 10.1021/js9601896 1:CAS:528:DyaK28XntlOqt7k%3D
11. M. Y. Heo Z. Z. Piao T. W. Kim Q. R. Cao A. Kim B. J. Lee 2005 Effect of solubilizing and microemulsifying excipients in polyethylene glycol 6000 solid dispersion on enhanced dissolution and bioavailability of ketoconazole Arch. Pharm. Res. 28 604 611 15974450 10.1007/BF02977766 1:CAS:528: DC%2BD2MXltVamtbw%3D (Pubitemid 44698739)
12. Higuchi, T. and Connors, A. K., in Reilley, C. N. (Ed.). Advances in Analytical Chemistry and Instrumentation. Interscience, New York, pp. 117-212, (1965).
13. A. S. Kearney D. L. Gabriel S. C. Mehta G. W. Radebaugh 1994 Effect of polyvinyl pyrrolidone on the crystallinity and dissolution rate of solid dispersions of the anti-inflammatory Ci-987 Int. J. Pharm. 104 169 174 10.1016/0378-5173(94)90192-9 1:CAS:528:DyaK2cXisFeitbg%3D (Pubitemid 24073701)
14. G. M. Khan Z. Jiabi 1998 Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers Drug Dev. Ind. Pharm. 24 455 462 9876608 10.3109/03639049809085643 1:CAS:528:DyaK1cXjt1eqsrs%3D (Pubitemid 28273136)
15. K. A. Khan 1975 The concept of dissolution efficiency J. Pharm. Pharmacol. 27 48 49 235616 1:CAS:528:DyaE2MXhsVCru7o%3D
16. N. Khan D. Q. Craig 2003 The influence of drug incorporation on the structure and release properties of solid dispersions in the lipid matrices J. Control. Release 93 355 368 14644585 10.1016/j.jconrel.2003.09.006 1:CAS:528:DC%2BD3sXptlCmsLg%3D (Pubitemid 37485957)
17. C. K. Kim Y. J. Cho Z. G. Gao 2001 Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery J. Control. Release 70 149 155 11166415 10.1016/S0168-3659(00)00343-6 1:CAS:528:DC%2BD3MXovV2quw%3D%3D (Pubitemid 32144799)
18. C. Leuner J. Dressman 2000 Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 47 60 10840192 10.1016/S0939-6411(00)00076-X 1:CAS:528:DC%2BD3cXjslyju7c%3D (Pubitemid 30326688)
19. E. Merisko-Liversidge G. G. Liversidge E. R. N. a. f. a. f. p.-w.-s. compounds. Cooper 2003 Eur. J. Pharm. Sci. 18 113 120 12594003 10.1016/S0928-0987(02)00251-8 1:CAS:528:DC%2BD3sXht1Kltrg%3D (Pubitemid 36184748)
20. A. Nokhodchi Y. Javadzadeh M. R. Siahi-Shadbad M. Barzegar-Jalali 2005 The effect of type and concentration of vehicles on dissolution rates of a poorly water soluble drug (indomethacin) from liquisolid compacts J. Pharm. Pharm. Sci. 8 18 25 15946594 1:CAS:528:DC%2BD2MXivVCgsb8%3D (Pubitemid 41528866)
21. S. Okonogi T. Oguchi E. Yonemochi S. Puttipipatkhachorn K. Yamamoto 1997 Improved dissolution of ofloxacin via solid dispersion Int. J. Pharm. 156 175 180 10.1016/S0378-5173(97)00196-8 1:CAS:528:DyaK2sXmsFWqsbc%3D (Pubitemid 27400005)
22. Paul, A. I., Gilman, A. G., Rall, T. W., Nies, A. S., and Taylor, P., Eds., Goodman and Gilman's, The pharmacological basis of therapeutics. 8th Edn., Mc Graw Hill, New York, pp 239 (1996).
23. B. Perissutti F. Rubessa F. Princivalle 2000 Solid dispersions of carbamazepine with Gelucire 44/14 and 50/13 STP Pharma Sci. 10 479 484 1:CAS:528:DC%2BD3MXot1Wjug%3D%3D (Pubitemid 32103932)
24. H. Rajashree K. Vilasrao 2009 Preparation and characterization of inclusion complexes of carvedilol with methyl-bcyclodextrin J. Incl. Phenom. Macrocyclic Chem. 63 219 224 10.1007/s10847-008-9506-5
25. R. R. Ruffolo D. A. Boyle D. P. Brooks 1992 Carvedilol: a novel cardiovascular drug with multiple actions Cardiovasc. Drug Rev. 10 127 157 10.1111/j.1527-3466.1992.tb00242.x 1:CAS:528:DyaK3sXksw%3D%3D
26. B. D. Shewale N. P. Sapkal N. A. Raut N. J. Gaikwad H. R. Fursule 2008 Effect of hydroxyl propyl-β-cyclodextrinon solubility of carvedilol Indian J. Pharm. Sci. 70 255 257 20046727 10.4103/0250-474X.41470 1:STN:280: DC%2BC3c%2FgtlGltw%3D%3D (Pubitemid 351920211)
27. S. L. Shimpi B. Chauhan K. R. Mahadik A. Paradkar 2005 Stabilization and improved in vivo performance of amorphous Etoricoxib using Gelucire 50/13 Pharm. Res. 22 1727 1734 16180131 10.1007/s11095-005-6694-1 1:CAS:528: DC%2BD2MXhtVent7vJ (Pubitemid 41355913)
28. X. Wen F. Tan Z. Jing Z. Liu 2004 Preparation and study the 1:2 inclusion complex of carvedilol with cyclodextrin J. Pharm. Biomed. Anal. 34 517 523 15127807 10.1016/S0731-7085(03)00576-4 1:CAS:528:DC%2BD2cXptFehuw%3D%3D (Pubitemid 38177341)